Supplementary Figure 7 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
PFS and OS by TcellinfGEP in participants with biliary tract cancer (cohort F)
Fields of Study & Subjects
Cholangiocarcinoma and Gallbladder Cancer Studies
Cancer Immunotherapy and Biomarkers
Pancreatic and Hepatic Oncology Research
Publication details
- Publication date
- 26 March 2026
- Language
- EN